Deciphering the cardioprotective effects of statins in anthracycline-related cardiac dysfunction: A systematic review and meta-analysis

Background: Cancer induced chronic inflammation and cancer drugs effects on the vascular system can lead to rapidly progressing atherosclerotic burden. Statins drugs are known to reduce atherosclerotic plaque burden and inflammation. We studied outcomes of statins for anthracycline-related cardiac d...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	American Journal of Preventive Cardiology
المؤلفون الرئيسيون:	Mubashar Karamat, Bilal Hussain, Munis Mahboob Ahmed, Mohammad Hamza, Junaid Mir, Ayedh Alamri, Aimen Shafiq, Yasar Sattar, Muhammad Zia Khan, Harshith Thyagaturu, Karthik Gonuguntla, Birjesh D Patel
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-12-01
الموضوعات:	Statins Cancer Anthracyclines Cardiac Dysfunction Chemotherapy Heart Failure
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2666667724002423

مواد مشابهة

Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
حسب: John Lee, وآخرون
منشور في: (2024-12-01)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
حسب: Parisa Firoozbakhsh, وآخرون
منشور في: (2024-05-01)

Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
حسب: Andia Taghdiri
منشور في: (2024-06-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
حسب: Rongrong Bai, وآخرون
منشور في: (2025-06-01)

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
حسب: S. Slavcheva
منشور في: (2024-05-01)

The cardiovascular system in patients with anthracycline cardiomiopathy
حسب: Alexandr T. Teplyakov, وآخرون
منشور في: (2017-10-01)

Anthracyclines
حسب: Alison Cheong, وآخرون
منشور في: (2018-12-01)

Natural language processing of electronic medical records identifies cardioprotective agents for anthracycline induced cardiotoxicity
حسب: Yoshimasa Kawazoe, وآخرون
منشور في: (2025-02-01)

Echocardiographic Changes after Treatment with Anthracyclines in Children
حسب: Hamid Amoozgar, وآخرون
منشور في: (2012-03-01)

Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients
حسب: Luigi Spadafora, وآخرون
منشور في: (2025-06-01)

Evaluating cardioprotective strategies for anthracycline-induced cardiotoxicity in breast cancer: insights from a systematic review and network meta-analysis
حسب: Runyu Liu, وآخرون
منشور في: (2025-07-01)

Survivorship clinic attendance improves completion but not timeliness of cardiac surveillance post anthracyclines
حسب: Zac Forbes, وآخرون
منشور في: (2025-02-01)

Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study
حسب: Xinye Li, وآخرون
منشور في: (2025-03-01)

Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
حسب: Yun Qiu, وآخرون
منشور في: (2023-12-01)

Clinical, Echocardiographic and Laboratory Cardiac Monitoring in Breast Cancer Patients Undergoing Chemotherapy with Anthracycline Agents: A Pilot Study on Cardioprotective Algorithms at Mohammad Hoesin General Hospital, Palembang
حسب: Indah Puspita
منشور في: (2025-07-01)

Racial and Ethnic Disparities in Cardiotoxicity in Patients With Cancer Treated With Anthracyclines
حسب: Lili Zhang, وآخرون
منشور في: (2025-04-01)

Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
حسب: Preety Negi, وآخرون
منشور في: (2014-01-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
حسب: M. Yu. Sinitsky, وآخرون
منشور في: (2021-10-01)

Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer
حسب: Azra Rašić, وآخرون
منشور في: (2019-02-01)

Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline‐Based Chemotherapy
حسب: David L. DeRemer, وآخرون
منشور في: (2023-05-01)

Functional investigation of the SAM-dependent methyltransferase RdmB in anthracycline biosynthesis
حسب: Moli Sang, وآخرون
منشور في: (2025-03-01)

Left Ventricular Longitudinal Strain Abnormalities in Childhood Exposure to Anthracycline Chemotherapy
حسب: Arnaud Rique, وآخرون
منشور في: (2024-03-01)

An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
حسب: Sicong Xie, وآخرون
منشور في: (2024-06-01)

Anthracycline-induced cardiac toxicity: A clinical review
حسب: Adil Abdelhameed Abbas, وآخرون
منشور في: (2019-01-01)

Creation of anthracycline prodrug
حسب: A. N. Tevyashova
منشور في: (2014-12-01)

Predictive Factors of Therapy-Related Cardiovascular Events in Patients with Lymphoma Receiving Anthracyclines
حسب: Alberto Lopez-Garcia, وآخرون
منشور في: (2024-04-01)

Electrocardiographic characteristics of Nigerian children on anthracycline-based chemotherapy: A preliminary report
حسب: I D Peter, وآخرون
منشور في: (2017-01-01)

MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances
حسب: Hongyun Mao, وآخرون
منشور في: (2025-08-01)

Correction: An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
حسب: Sicong Xie, وآخرون
منشور في: (2025-09-01)

Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity
حسب: Fibi Meshrkey, وآخرون
منشور في: (2025-09-01)

Comprehensive Analysis of Transcriptomics and Genetic Alterations Identifies Potential Mechanisms Underlying Anthracycline Therapy Resistance in Breast Cancer
حسب: Zihao Liu, وآخرون
منشور في: (2022-12-01)

The Effect of Anthracycline Chemotherapy on Arterial Stiffness
حسب: Mürsel Şahin, وآخرون
منشور في: (2020-06-01)

An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study
حسب: Jukapun Yoodee, وآخرون
منشور في: (2021-08-01)

Exploring Anthracycline-Induced Cardiotoxicity from the Perspective of Protein Quality Control
حسب: Shanshan Li, وآخرون
منشور في: (2024-06-01)

DNA damage independent inhibition of NF-κB transcription by anthracyclines
حسب: Angelo Ferreira Chora, وآخرون
منشور في: (2022-12-01)

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
حسب: Tian-Wei Wang, وآخرون
منشور في: (2019-10-01)

Previous treatment with anthracycline does not affect the course of sepsis in cancer patients: Retrospective cohort study
حسب: Camille Windsor, وآخرون
منشور في: (2025-01-01)

Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study
حسب: Prathana Nathan, وآخرون
منشور في: (2022-12-01)

Treatment related acute promyelocytic leukemia (t-APML) in breast cancer survivor treated with anthracycline based chemotherapy: rare case report
حسب: Irappa Madabhavi, وآخرون
منشور في: (2016-02-01)

Cardioprotective effect of thiotriazoline in cancer patients
حسب: A. V. Koltsov, وآخرون
منشور في: (2023-02-01)